TLR8 agonist 4
TLR8 agonist 4 showed effective inhibition on wild-type and drug-resistant (lamivudine and entecavir) HBV strains. The IC50 values are 0.15 and 0.10 respectively μM.
For research use only. We do not sell to patients.
- CAS No.: 2761697-69-0
- Formula: C28H27N5O5S
- Molecular Weight:545.61
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
HBV 0.10 μM (IC50) |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HepG2 2.2.15 | CC50 |
>10 μM
Compound: 5l
|
Cytotoxicity against human HepG2 2.2.15 cells infected with Hepatitis B virus assessed as reduction in cell growth by CCK8 assay
Cytotoxicity against human HepG2 2.2.15 cells infected with Hepatitis B virus assessed as reduction in cell growth by CCK8 assay
|
[PMID: 35123297] |
| HepG2 2.2.15 | IC50 |
0.15 μM
Compound: 5l
|
Antiviral activity against Hepatitis B virus infected in human HepG2 2.2.15 cells assessed as inhibition of DNA replication
Antiviral activity against Hepatitis B virus infected in human HepG2 2.2.15 cells assessed as inhibition of DNA replication
|
[PMID: 35123297] |
Chemical Information
-
CAS No. 2761697-69-0
-
Molecular Weight 545.61
-
Formula C28H27N5O5S
-
SMILES
COC1=C(C=CC=C1)CSC2=NC3=CC=C(C=C3C(N2CC4=CC=CO4)=O)OCCCOC5=NC(N)=NC=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)